Interventional therapy for hypertension: Back on track again?

Area of Science:

• Cardiology
• Nephrology
• Vascular Surgery

Background:

• Resistant hypertension is defined as blood pressure above target despite optimal doses of at least three antihypertensive agents, including a diuretic.
• Accurate diagnosis involves excluding pseudoresistance, identifying secondary causes of hypertension, and evaluating contributing concomitant conditions.
• Identifying true resistant hypertension is crucial for selecting patients who may benefit from invasive therapeutic strategies.

Purpose of the Study:

• To review the rationale and clinical outcomes of current invasive interventional approaches for treating resistant hypertension.

Main Methods:

• Review of existing literature on invasive therapies for resistant hypertension.
• Focus on three primary interventional approaches: renal sympathetic nerve ablation, baroreceptor stimulation, and peripheral arterial venous anastomosis.
• Analysis of the underlying principles and reported clinical results for each method.

Main Results:

• Renal nerve ablation aims to reduce sympathetic nervous system activity.
• Baroreceptor stimulation targets the body's natural blood pressure regulation mechanisms.
• Arterial venous anastomosis creates a direct connection between arteries and veins to alter hemodynamics.
• Clinical results for these invasive therapies are under evaluation for efficacy and safety.

Conclusions:

• Invasive therapies represent a significant advancement in managing treatment-resistant hypertension.
• Renal nerve ablation, baroreceptor stimulation, and arterial venous anastomosis offer distinct mechanisms for blood pressure control.
• Further research and clinical data are essential to establish the long-term efficacy and role of these interventions in resistant hypertension management.